- Home
- EOLS vs BWMX Comparison
EOLS vs BWMX Comparison
Compare EOLS & BWMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EOLS
- BWMX
- Stock Information
- Founded
- EOLS 2012
- BWMX 1995
- Country
- EOLS United States
- BWMX Mexico
- Employees
- EOLS N/A
- BWMX N/A
- Industry
- EOLS Biotechnology: Pharmaceutical Preparations
- BWMX Catalog/Specialty Distribution
- Sector
- EOLS Health Care
- BWMX Consumer Discretionary
- Exchange
- EOLS Nasdaq
- BWMX Nasdaq
- Market Cap
- EOLS 417.9M
- BWMX 495.6M
- IPO Year
- EOLS 2018
- BWMX N/A
- Fundamental
- Price
- EOLS $6.96
- BWMX $14.02
- Analyst Decision
- EOLS Strong Buy
- BWMX Strong Buy
- Analyst Count
- EOLS 4
- BWMX 2
- Target Price
- EOLS $21.25
- BWMX $22.50
- AVG Volume (30 Days)
- EOLS 1.4M
- BWMX 47.8K
- Earning Date
- EOLS 11-05-2025
- BWMX 10-23-2025
- Dividend Yield
- EOLS N/A
- BWMX 10.34%
- EPS Growth
- EOLS N/A
- BWMX 15.49
- EPS
- EOLS N/A
- BWMX 1.49
- Revenue
- EOLS $285,823,000.00
- BWMX $775,128,445.00
- Revenue This Year
- EOLS $13.39
- BWMX $3.50
- Revenue Next Year
- EOLS $26.85
- BWMX $5.30
- P/E Ratio
- EOLS N/A
- BWMX $9.58
- Revenue Growth
- EOLS 15.10
- BWMX 3.60
- 52 Week Low
- EOLS $5.71
- BWMX $7.00
- 52 Week High
- EOLS $17.44
- BWMX $15.00
- Technical
- Relative Strength Index (RSI)
- EOLS 55.80
- BWMX 56.84
- Support Level
- EOLS $6.08
- BWMX $13.61
- Resistance Level
- EOLS $7.76
- BWMX $14.43
- Average True Range (ATR)
- EOLS 0.40
- BWMX 0.61
- MACD
- EOLS 0.04
- BWMX 0.04
- Stochastic Oscillator
- EOLS 54.17
- BWMX 63.00
About EOLS Evolus Inc.
Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.
About BWMX Betterware de Mexico S.A.P.I. de C.V.
Betterware de Mexico SAPI de CV is a direct-to-consumer selling company. The company operates through two business segments: the home organization products (Betterware segment or BWM segment) and the beauty and personal care products (B and PC) (JAFRA segment). The Betterware's segment is divided in seven categories of the home organization: Kitchen and food preservation, Home solutions, Bedroom, Bathroom, Laundry & Cleaning, Tech & mobility and wellness. The JAFRA's segment is divided into four categories beauty and personal care: fragrance, color (cosmetics), skin care and toiletries. The company generates a majority of its revenue from the Beauty and personal care (B&PC) (JAFRA segment). Geographically, key revenue for the company is derived from Mexico.